Skip to main content
TIANYU BIO-TECHNOLOGY CO.,LTD. logo

TIANYU BIO-TECHNOLOGY CO.,LTD. — Investor Relations & Filings

Ticker · 603717 ISIN · CNE1000030W1 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 1,621 across all filing types
Latest filing 2024-03-28 Capital/Financing Update
Country CN China
Listing Shanghai Stock Exchange 603717

About TIANYU BIO-TECHNOLOGY CO.,LTD.

https://www.tianyubiotech.com/

TIANYU BIO-TECHNOLOGY CO.,LTD. specializes in the research, development, and large-scale production of active pharmaceutical ingredients (APIs) and advanced pharmaceutical intermediates. The company focuses on therapeutic areas such as cardiovascular health, diabetes management, and anti-viral treatments. Its core product portfolio includes various sartan-based intermediates and other complex organic synthesis products. TIANYU BIO-TECHNOLOGY emphasizes rigorous quality management systems and adheres to international regulatory standards to ensure product safety and efficacy. By leveraging advanced chemical synthesis technologies and a robust R&D infrastructure, the company provides customized manufacturing solutions and high-quality chemical components to global pharmaceutical partners. Its operations are characterized by a commitment to technical innovation and process optimization in the synthesis of complex molecules.

Recent filings

Filing Released Lang Actions
关于公司2023年度对外担保预计的进展公告
Capital/Financing Update Classification · 95% confidence The document is an announcement from Tianyu Ecological Environment Co., Ltd. regarding the progress of external guarantees for the year 2023. It details the guarantee amount, the parties involved, internal decision procedures, and financial data of the guaranteed subsidiary. The document is relatively short (2640 characters) and focuses on a specific financial guarantee update rather than a full financial report or audit. It does not contain comprehensive financial statements or detailed financial analysis. The content fits the category of a regulatory announcement about financing or capital-related activities, specifically about guarantees provided by the company. Therefore, the most appropriate classification is Capital/Financing Update (CAP).
2024-03-28 Chinese
关于2022年股票期权激励计划首次授予股票期权第一个行权期限制行权期间的提示性公告
Capital/Financing Update Classification · 95% confidence The document is a public announcement from a company regarding the restriction period for exercising stock options under its 2022 stock option incentive plan. It specifies dates for the restriction period and compliance with regulatory requirements. The content is about a capital-related update concerning stock options and their exercise restrictions, not a full report or financial statement. The document length is short (666 characters), and it is an announcement rather than a detailed report. Therefore, it fits best under Capital/Financing Update (CAP).
2024-03-25 Chinese
关于部分募投项目延期的进展公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the progress and delay of certain fundraising investment projects by the company. It details contract adjustments and project timeline extensions. There is no financial data, no report attached or referenced as being published, and no mention of annual or interim reports. The content is about project progress and contractual updates related to capital projects. This fits best under Capital/Financing Update (CAP) as it relates to fundraising project delays and contract amendments.
2024-03-22 Chinese
关于实际控制人续签一致行动协议的公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding the renewal of a shareholders' agreement (一致行动协议) between the actual controllers of the company, detailing their coordinated actions and voting agreements. It does not contain financial statements, audit information, or any report data. It is a regulatory announcement about shareholder agreements and control, not a financial report or management change announcement. It fits best under Regulatory Filings (RNS) as it is a general regulatory announcement about shareholder agreements and control without fitting other specific categories.
2024-03-18 Chinese
股票交易异常波动公告
Regulatory Filings Classification · 95% confidence The document is a stock trading abnormal fluctuation announcement by Tianyu Ecological Environment Co., Ltd. It discusses the stock price movements over specific dates, references prior earnings forecasts, and clarifies that no undisclosed material information exists. It does not contain actual financial statements or detailed financial data but rather serves as a regulatory disclosure about stock price volatility and related risk warnings. The document length is 2437 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2024-03-08 Chinese
控股股东、实际控制人关于《天域生态环境股份有限公司股票交易异常波动的问询函》的回复
Regulatory Filings
2024-03-08 Chinese

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.